Stocks to sell

Value investors are at a loss to explain the performance of Alibaba (NYSE:BABA) stock. Holding BABA stock in the hopes that the shares can return to their 52-week high may prove to be unprofitable. Source: BigTunaOnline / Shutterstock.com That’s because China’s government is introducing stricter regulations in many sectors. So despite paying a $2.75 billion

A month ago I wrote that Uber (NYSE:UBER) was likely to fall 20% from $49.07 on July 9, and not rise over 42% like other analysts were saying. Since then, UBER stock has dropped over 17% to below $40 and is still falling. Source: NYCStock / Shutterstock.com I suspect that, given another lousy loss-making quarter by

Although I’m a car enthusiast, I’m not in love with Nio (NYSE:NIO) stock. In fact, I’ve repeatedly suggested that investors avoid it in the past. Source: xiaorui / Shutterstock.com In 2020 I wrote the article “Nio Stock Has Skyrocketed in 2020, But High Risks Remain” using the Nasdaq Dozen method to analyze the company, I focused

On Aug. 18, Nano Dimension (NASDAQ:NMDM) issued its second-quarter earnings, indicating it had $1.397 billion in cash on its balance sheet. But based on my calculations, using info from the release, NNDM stock now has a market value of $1.537 billion. This is $140.087 million or just $10% over its cash balance. It might possibly

Hyliion Holdings Corp. (NYSE:HYLN) stock is down 51% so far in 2021, consistent with my pessimistic position on SPACs: enthusiasm for businesses with poor fundamentals leads to a short-term rise of the stock, which soon deflates when reality kicks in. Source: Hyliion media I have said many times that I do not like SPACs, as

For the quarter ending May 1, 2021, GameStop (NYSE:GME) was able to reduce its total store count by 12% year-over-year (YoY), according to its first-quarter earnings release. As a result, the company’s losses fell from $165.1 million or $2.65 per share last year to just $66.8 million or $1.01 per share this quarter. This is

As I write this, you couldn’t craft a more dichotomous circumstance for Airbnb (NASDAQ:ABNB), the popular — and to some circles, infamous — online marketplace for lodgings. Following a strong earnings report for the second quarter of 2021, ABNB stock should be flying high instead of Monday’s 2.74% decline. Source: AngieYeoh / Shutterstock.com What gives?

Atossa Therapeutics (NASDAQ:ATOS) is a clinical-stage biotech company whose surge in 2021 soon proved to be unsustainable. It underwent a meteoric rise from $1.52 in April to a 52-week high of $9.80 in June. But now it’s back down to the $3.20 area. And looking at key financial metrics it is enough for me to

It hasn’t been a fun ride for Workhorse (NASDAQ:WHKS) stock. Source: rblfmr / Shutterstock.com In fact, most start-up EV, low-quality special purpose acquisition companies (SPACs) and high-growth stocks have struggled over the past few months. In the case of WKHS stock, shares remain 76% below the all-time high set in February. Unfortunately for Workhorse, earnings aren’t

For several reasons, investors should avoid Meta Materials (NASDAQ:MMAT) stock. Source: Yuriy Golub / Shutterstock.com Although MMAT stock does appear to have a great deal of potential,  its technology is too unproven and its valuation is too high to makes its shares a worthwhile holding at this point. Additionally, Meta’s status as a meme stock also

Stocks have made a good run so far this year, yet we’re running into a familiar space in the past 18 months: uncertainty. Some investors look to dividend stocks now, for safety and value. That can be a good strategy, since many investors have bid up growth stocks to crazy levels and dividend stocks have

The best words to describe my view on the markets is cautiously optimistic. Over the medium to long term, it’s likely that equities will trend higher. However, the markets seem too frothy at this point of time, leaving investors to consider which stocks to avoid. Because the S&P 500 index trading at a cyclically adjusted

“The pill that moves the needle.” This is the statement highlighted on Vaxart’s (NASDAQ:VXRT) website, and it is written to make a bold impression. Recently, the company has been in the spotlight for its Covid-19 vaccine that is notably in pill form. Its inoculation isn’t ready yet, but some investors have already picked up shares

Ever since Nano Dimension (NASDAQ:NNDM) peaked in Feb. 2021 and trended lower, Meta Materials (NASDAQ:MMAT) stock followed. Source: BLAGORODEZ / Shutterstock.com On Aug. 5, Meta Materials announced an indirect acquisition of Nanotech Security for CAD 90.8 million. Meta, whose technology platform delivers highly functional and sustainable materials, wants Nanotech for its authentication and brand protection

Senseonics Holdings (NYSEAMERICAN:SENS) develops medical technology, including “continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa.” The company’s product line includes implantable CGM systems that go under the user’s skin and a removable, rechargeable transmitter that works with an app made by the company. SENS

Marin Software (NASDAQ:MRIN), which makes enterprise software for the advertising industry, cratered over the last month. I think it is likely to still drop further. MRIN stock closed at $14.45 on July 12 when I wrote that it was likely to drop much further. At the close on Aug. 12, it was at $5.67 and

Seemingly out of nowhere, presidential and mayoral candidate Andrew Yang brought to the mainstream several ideas that absolutely needed to be talked about, one of them being data as the current century’s gold or oil. Since data is so valuable, it can theoretically fund multiple initiatives. For Palantir Technologies (NYSE:PLTR), that sounds just about right.

I have written two articles about Ocugen (NASDAQ:OCGN) in the past and I must say that if I had to summarize OCGN stock in two words, they would be irrational exuberance. Source: shutterstock.com/PhotobyTawat As of August 9, 2021, the company has a market valuation of $1.61 billion with zero revenue for 2019 and 2018. Yahoo!

The stock market has been incredibly volatile in the past couple of months. Investors are anxious about a marked increase in Covid-19 cases due to the latest Delta variant. The variant has become a dominant strain even in countries with high vaccination rates. Moreover, the recent disappointing jobs data has also led to a slowdown

Every time that I’m asked to write about Ocugen (NASDAQ:OCGN) I must remind myself that OCGN stock was caught up in the meme-stock craze earlier this year. And with short interest in the stock still above 20%, I suppose there are several traders who have little choice other than to hold on and hope for the